Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.
about
Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors.The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Ovarian cancer G protein coupled receptor 1 suppresses cell migration of MCF7 breast cancer cells via a Gα12/13-Rho-Rac1 pathwayNeuropeptide G Protein-Coupled Receptors as Oncotargets.
P2860
Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Somatostatin receptors in non- ...... tatin analogs in solid tumors.
@en
Somatostatin receptors in non- ...... tatin analogs in solid tumors.
@nl
type
label
Somatostatin receptors in non- ...... tatin analogs in solid tumors.
@en
Somatostatin receptors in non- ...... tatin analogs in solid tumors.
@nl
prefLabel
Somatostatin receptors in non- ...... tatin analogs in solid tumors.
@en
Somatostatin receptors in non- ...... tatin analogs in solid tumors.
@nl
P2093
P2860
P356
P1433
P1476
Somatostatin receptors in non- ...... tatin analogs in solid tumors.
@en
P2093
Herbert A Schmid
Jens Hasskarl
Martina Kaufmann
P2860
P304
P356
10.2217/FON.11.66
P407
P577
2011-07-01T00:00:00Z